Immunomodulatory effect

Immunomodulatory effect" is not a specific molecule, receptor, or defined therapeutic target. Instead, it refers to the general ability of a substance—such as a drug or biological agent—to modify or regulate the immune system's activity. This can involve either stimulating or suppressing immune responses depending on the clinical context. Immunomodulators are used in treating various diseases including cancer, autoimmune disorders (like lupus and rheumatoid arthritis), inflammatory bowel disease, allergies, and infections[1][2][3]. Examples of immunomodulatory drugs include thalidomide, lenalidomide, pomalidomide (used in multiple myeloma), Bacillus Calmette–Guérin (BCG) for bladder cancer and tuberculosis vaccination, and imiquimod cream for skin cancers[2]. The term "immunomodulatory effect" is too broad to be considered a canonical therapeutic target; rather it describes an action that can be mediated by many different molecules with diverse mechanisms of action such as altering cytokine production or modulating immune cell function[1][4]. Therefore, this entry is not suitable as a structured molecular target.

Other names

ImmunomodulationImmunomodulator effectImmune modulation